MonBe — Company Deck
0 / 0
Tip: Use the Print button to export one slide per PDF page.

MonBe

"See your baby feed."

$2.31B
Global breastfeeding accessories market
60–70%
Target gross margins
$400–600
LTV per family

TL;DR

Problem & Why Now

Parents lack objective milk-intake data; anxiety drives early cessation. Mature, low-cost sensors + on-device AI now enable consumer-grade accuracy without disrupting nursing.

Market

$2.31B global market; directly addressable ~$100–200M in early tech-adopter segment; expected 12–15% CAGR.

Advantage

Non-disruptive, breast-mounted multi-sensor patch; RF-silent during feeds (post-session NFC); favorable patent landscape.

Team & Scale

Founder-led with deep HW/embedded experience; rapid consumer entry, followed by clinical reporting and international expansion.

Business Model

Hardware kit + recurring patches + software subscription; target CAC $50–75; LTV $400–600; 60–70% blended gross margins.

The Problem

Breastfeeding is the gold standard, yet 80–90% of mothers rely on indirect cues to gauge intake. 35–44% stop early due to perceived insufficiency.

Vulnerable infants: Preterm babies need precise intake for development.
Combination feeding: No objective split between breast milk and formula.
Night feeding: Hard to distinguish nutritive vs comfort sucking.
Clinical burden: 5–7 minutes spent reconstructing history; 68% of records incomplete.

Our Solution

MonBe is a gentle, smart, breast-mounted sticker that listens to sucking, swallowing, and breathing to deliver real-time feeding insights—without disrupting nursing.

MonBe Daily: Real-time intake and latch quality.
MonBe Nightie: Sleep-optimized classification of eating vs comfort.
MonBe Care: Provider reports and clinical integration.
MonBe To-Go: Discreet cover with integrated patch support.

How It Works

5-Sensor Fusion

Acoustic microphone, micro-vibration (jaw), temperature (let-down), 4-electrode bioimpedance, pressure (suction).

Clinical accuracy target: ±5% (final product).

User Flow

1) Apply patch (30s) 2) Feed naturally 3) Tap phone to sync (<3s) 4) View AI insights.

Market

$2.31BGlobal market
$4.20B2033 projection
$100–200MAddressable segment
12–15%CAGR

US: ~3.3M mothers initiate annually; EU/IL initiation 80–95%.

Traction & Validation

Provisional patent filed Aug 2025.
Concept design and architecture finalized.
Competitive & patent analysis complete.

Planned Timeline (post-investment)

M1–6 MVP • M7–10 50+ mother pilots • M11–16 launch prep • M17–20 DTC launch

Competition

Infant Thrive — $299+, clinical focus only
Coro Shield — $199, nipple shield rejection
Hatch Scale — $149, disrupts feeding
MonBe — $150–250, non‑disruptive, multi‑sensor patch

Business Model

Revenue Streams

Reusable core $50–100 • Daily patches $30–50/mo • Software $5–15/mo • Clinic licensing

Unit Economics

CAC $50–75 • LTV $400–600 • 60–70% gross margins • Reimbursement path

Go‑to‑Market

Digital: Social, forums, influencers
Healthcare: Lactation, pediatrics
Retail: Amazon, Target, specialty
Direct: Website subscriptions

Phase 1 Israel • Phase 2 US DTC • Phase 3 EU • Phase 4 Healthcare

Team & Advisors

Founder & CEO — Eitan Halfon

ECE background; hardware, embedded, IoT; product leadership; military officer; SolarEdge alum.

Advisors & Partners (In Progress)

Clinical advisor (IBCLC) • FDA regulatory advisor • Med device manufacturer

Hiring: HW & SW Eng (Q4'25), Product & Mfg (Q1'26), Clinical & Marketing (Q2'26)

Financials & Funding

Rounds

Pre‑Seed $600K — R&D+Team $500K (83%), Reg+IP $100K (17%)

Seed $3–5M — R&D $1.5M (50%), Reg $0.5M (17%), Team $1M (33%)

Path to Profitability

Break-even ~Month 30 • GM 60–70% • Peak burn ~$200K/mo • 24+ months runway

Use of Funds: Product (50%) • Team (33%) • Reg & IP (17%)

Competitive Advantage & IP

Only breast‑mounted multi‑sensor patch
Post‑session analysis (no RF during feeding)
Complete ecosystem (Daily/Nightie/Care/To‑Go)
Provisional patent filed Aug 2025
Favorable landscape; foundational patents expired

Vision & Impact

Make MonBe the universal standard for breastfeeding support. Empower every parent with clarity, reduce premature cessation, and improve infant outcomes globally.

Why Now: Disposable device adoption, digital health acceleration, maternal health focus, matured sensors & AI.

Contact

Email: hello@monbecare.com

Investors: investors@monbecare.com

Phone: +972-52-4042-798

More: home, story, and pitch at monbecare.com